Timothy C. Barabe - Jan 2, 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Director
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy C. Barabe
Stock symbol
RNAC
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/6/2025, 04:20 PM
Previous filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Award $0 +2.6K +11.95% $0.00 24.4K Jan 2, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Stock Option (Right to Buy) Award $0 +7.8K $0.00 7.8K Jan 2, 2025 Common Stock 7.8K $16.93 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.